Commentary: Treatment outcome of different chemotherapy in patients with relapsed or metastatic malignant urachal tumor
Author: | Tibor SzarvasORCiDGND, Henning ReisORCiDGND |
---|---|
URN: | urn:nbn:de:hebis:30:3-739501 |
DOI: | https://doi.org/10.3389/fonc.2022.864708 |
ISSN: | 2234-943X |
Parent Title (English): | Frontiers in oncology |
Publisher: | Frontiers Media |
Place of publication: | Lausanne |
Document Type: | Article |
Language: | English |
Date of Publication (online): | 2022/05/30 |
Date of first Publication: | 2022/05/30 |
Publishing Institution: | Universitätsbibliothek Johann Christian Senckenberg |
Release Date: | 2023/06/02 |
Tag: | chemotherapy; cisplatin; molecular pathology; outcome; survival; urachal cancer |
Volume: | 12 |
Issue: | art. 864708 |
Article Number: | 864708 |
Page Number: | 3 |
First Page: | 1 |
Last Page: | 3 |
Note: | Kommentar zu: Chen M, Xue C, Huang R-q, Ni M-q, Li L, Li H-f, Yang W, Hu A-q, Zheng Z-s, An X and Shi Y (2021) Treatment Outcome of Different Chemotherapy in Patients With Relapsed or Metastatic Malignant Urachal Tumor. Front. Oncol. 11:739134. doi: 10.3389/fonc.2021.739134. |
Institutes: | Medizin / Medizin |
Dewey Decimal Classification: | 6 Technik, Medizin, angewandte Wissenschaften / 61 Medizin und Gesundheit / 610 Medizin und Gesundheit |
Sammlungen: | Universitätspublikationen |
Licence (German): | Creative Commons - CC BY - Namensnennung 4.0 International |